发明授权
US09303035B2 Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel 有权
取代的吡嗪并[1',2':1,2]吡咯并[3,4-d]嘧啶,嘧啶并[4',5':3,4]吡咯并[2,1-c] [1,4] 嘧啶并[4',5':3,4]吡咯并[1,2-d] [1,4]氧氮杂用于抑制CFTR通道

Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel
摘要:
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
公开/授权文献
信息查询
0/0